{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:42:05Z","timestamp":1787643725216,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To document <jats:sup>18<\/jats:sup>F-Fluorodeoxyglucose positron emission tomography\/computed tomography (PET\/CT) findings after percutaneous cryoablation for early breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data of 193 consecutive patients who had undergone cryoablation for invasive ductal carcinoma or ductal carcinoma in situ\u2009\u2264\u200915\u2009mm without a history of ipsilateral breast cancer, synchronous ipsilateral lesion, and with estrogen receptor positive\/human epidermal growth factor 2 negative were enrolled. The imaging characteristics of the treated areas were evaluated and classified on CT images as one of two types: fatty mass or non-fatty mass type. The maximum standardized uptake value (SUVmax) of the initial post-cryoablation PET\/CT, the CT type of the treated area and selected clinical factors (age, menopausal status, lesion area, breast density, timing of PET\/CT) were retrospectively evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median interval between cryoablation and the initial post-cryoablation PET\/CT was 12\u2009months. The median SUVmax of the treated area was 1.36. The CT findings of the treated area were classified as fatty mass type (<jats:italic>n<\/jats:italic>\u2009=\u2009137, 71.0%) or non-fatty mass type (<jats:italic>n<\/jats:italic>\u2009=\u200956, 29.0%). The treated areas of patients with lower breast density, of older age, post-menopausal status, and lower radiation dose were significantly more likely to be of fatty mass type (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Non-fatty mass type averaged a significantly higher SUVmax than did fatty mass type.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Post-cryoablation PET\/CT findings are of fatty or non-fatty mass type. A non-fatty appearance, which can show higher SUVmax, does not necessarily denote recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-020-00325-y","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T09:02:46Z","timestamp":1594890166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fluorodeoxyglucose positron emission tomography\/computed tomography findings after percutaneous cryoablation of early breast cancer"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-9427","authenticated-orcid":false,"given":"Takuya","family":"Adachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Fukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"issue":"5","key":"325_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000355707","volume":"8","author":"G Manenti","year":"2013","unstructured":"Manenti G, Scarano AL, Pistolese CA, Perretta T, Bonanno E, Orlandi A, et al. Subclinical breast cancer: minimally invasive approaches. Our experience with percutaneous radiofrequency ablation vs. cryotherapy. Breast Care. 2013;8(5):356\u201360.","journal-title":"Breast Care"},{"issue":"6","key":"325_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jvir.2015.02.010","volume":"26","author":"TD Atwell","year":"2015","unstructured":"Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol. 2015;26(6):792\u20139.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"325_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bju.12370","volume":"113","author":"M Durand","year":"2014","unstructured":"Durand M, Barret E, Galiano M, Rozet F, Sanchez-Salas R, Ahallal Y, et al. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int. 2014;113(1):56\u201364.","journal-title":"BJU Int"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/hep.27548","volume":"61","author":"C Wang","year":"2015","unstructured":"Wang C, Wang H, Yang W, Hu K, Xie H, Hu K, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61:1579\u201390.","journal-title":"Hepatology."},{"issue":"3","key":"325_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2214\/AJR.19.21329","volume":"213","author":"RC Ward","year":"2019","unstructured":"Ward RC, Lourenco AP, Mainiero MB. Ultrasound-guided breast cancer cryoablation. Am J Roentgenol. 2019;213(3):716\u201322.","journal-title":"Am J Roentgenol"},{"issue":"10","key":"325_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jvir.2009.06.029","volume":"20","author":"PJ Littrup","year":"2009","unstructured":"Littrup PJ, Jallad B, Chandiwala-Mody P, D\u2019Agostini M, Adam BA, Bouwman D. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol. 2009;20(10):1329\u201341.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"325_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2214\/AJR.13.12325","volume":"204","author":"SP Poplack","year":"2015","unstructured":"Poplack SP, Levine GM, Henry L, Wells WA, Heinemann FS, Hanna CM, et al. A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection. Am J Roentgenol. 2015;204(5):1100\u20138.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"325_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10147-019-01448-4","volume":"24","author":"M Takada","year":"2019","unstructured":"Takada M, Toi M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol. 2019;24(6):608\u201313.","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"325_CR9","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s00330-016-4668-9","volume":"27","author":"G Mauri","year":"2017","unstructured":"Mauri G, Sconfienza LM, Pescatori LC, Fedeli MP, Al\u00ec M, Di Leo G, et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: a systematic review and meta-analysis. Eur Radiol. 2017;27(8):3199\u2013210.","journal-title":"Eur Radiol"},{"issue":"2","key":"325_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.12110853","volume":"266","author":"D Groheux","year":"2013","unstructured":"Groheux D, Espi\u00e9 M, Giacchetti S, Hindi\u00e9 E. Performance of FDG PET\/CT in the clinical management of breast cancer. Radiology. 2013;266(2):388\u2013405.","journal-title":"Radiology."},{"issue":"6","key":"325_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.acra.2018.07.012","volume":"26","author":"Y Machida","year":"2019","unstructured":"Machida Y, Shimauchi A, Igarashi T, Fukuma E. MRI findings after cryoablation of primary breast cancer without surgical resection. Acad Radiol. 2019;26(6):744\u201351.","journal-title":"Acad Radiol"},{"issue":"3","key":"325_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"325_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1023\/A:1026514032085","volume":"11","author":"AY El-Bastawissi","year":"2000","unstructured":"El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control. 2000;11(10):955\u201363.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"325_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrc3672","volume":"14","author":"KF Chu","year":"2014","unstructured":"Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199\u2013208.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"325_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5114\/pjp.2014.42665","volume":"65","author":"MR Gajda","year":"2014","unstructured":"Gajda MR, Mireskandari M, Baltzer PA, Pfleiderer SO, Camara O, Runnebaum IB, et al. Breast pathology after cryotherapy. Histological regression of breast cancer after cryotherapy. Pol J Pathol. 2014;65(1):20\u20138.","journal-title":"Pol J Pathol"},{"issue":"1","key":"325_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-015-0058-3","volume":"12","author":"FM Di Maggio","year":"2015","unstructured":"Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, et al. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm. 2015;12(1):1\u201311.","journal-title":"J Inflamm"},{"issue":"4","key":"325_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejso.2009.11.009","volume":"36","author":"TS Aukema","year":"2010","unstructured":"Aukema TS, Rutgers EJT, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MTFD, et al. The role of FDG PET\/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques. Eur J Surg Oncol. 2010;36(4):387\u201392.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"325_CR18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/cncr.25727","volume":"117","author":"L Champion","year":"2011","unstructured":"Champion L, Brain E, Giraudet AL, Le Stanc E, Wartski M, Edeline V, et al. Breast cancer recurrence diagnosis suspected on tumor marker rising. Cancer. 2011;117(8):1621\u20139.","journal-title":"Cancer."},{"issue":"2","key":"325_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00259-010-1626-7","volume":"38","author":"L Evangelista","year":"2011","unstructured":"Evangelista L, Baretta Z, Vinante L, Cervino AR, Gregianin M, Ghiotto C, et al. Tumour markers and FDG PET\/CT for prediction of disease relapse in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2011;38(2):293\u2013301.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"325_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ejrad.2010.04.029","volume":"80","author":"G Grassetto","year":"2011","unstructured":"Grassetto G, Fornasiero A, Otello D, Bonciarelli G, Rossi E, Nashimben O, et al. 18F-FDG-PET\/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study. Eur J Radiol. 2011;80(3):828\u201333.","journal-title":"Eur J Radiol"},{"issue":"11","key":"325_CR21","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/cncr.22292","volume":"107","author":"L Radan","year":"2006","unstructured":"Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O. The role of FDG-PET\/CT in suspected recurrence of breast cancer. Cancer. 2006;107(11):2545\u201351.","journal-title":"Cancer."},{"issue":"1","key":"325_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejrad.2007.10.021","volume":"65","author":"GP Schmidt","year":"2008","unstructured":"Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol. 2008;65(1):47\u201358.","journal-title":"Eur J Radiol"},{"issue":"955","key":"325_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1259\/bjr\/17395663","volume":"80","author":"P Veit-Haibach","year":"2007","unstructured":"Veit-Haibach P, Antoch G, Beyer T, Stergar H, Schleucher R, Hauth EAM, et al. FDG-PET\/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol. 2007;80(955):508\u201315.","journal-title":"Br J Radiol"},{"issue":"4","key":"325_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/01.rct.0000284394.83696.42","volume":"31","author":"AR Haug","year":"2007","unstructured":"Haug AR, Schmidt GP, Klingenstein A, Heinemann V, Stieber P, Priebe M, et al. F-18-fluoro-2-deoxyglucose positron emission tomography\/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers. J Comput Assist Tomogr. 2007;31(4):629\u201334.","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"325_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11307-005-0013-4","volume":"7","author":"BJ Fueger","year":"2005","unstructured":"Fueger BJ, Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, et al. Performance of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography and integrated PET\/CT in restaged breast cancer patients. Mol Imaging Biol. 2005;7(5):369\u201376.","journal-title":"Mol Imaging Biol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-020-00325-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:08:11Z","timestamp":1626394091000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-00325-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-00325-y","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval from the research committee of the author\u2019s institution in accordance with the Helsinki Declaration, and written informed consent was waived by the Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}